NAPIGEN, INC.

NAPIGEN, INC.

A biotech company that addresses novel genome engineering of various organisms such as plants, microbes and animals.

Founded 2016

Wilmington, United States 21 employees Grant Total: $7.85M Agriculture, Biotechnology +1

NAPIGEN, INC., founded in 2016, is a pioneering biotechnology company with a focus on innovative genome engineering across a diverse spectrum of organisms, including plants, microbes, and animals. The company's unique approach involves targeting two crucial cellular components, mitochondria and chloroplasts, which house their own DNA and are essential for energy production and biochemical synthesis.

Specializing in Agriculture, Biotechnology, and AgriTech, NAPIGEN's technology has widespread applications in industrial biotechnology, agriculture, and animal and human healthcare. Their mission to leverage the potential of organelles is positioned to benefit industries and improve society.

Headquartered in the United States, the company secured its last investment through a Grant investment on 11 March 2024, facilitated by the U.S. Department of Agriculture. This backing highlights confidence in the firm’s potential to innovate and impact various sectors significantly.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	Undisclosed	1	U.S. Department of Agriculture	11 Mar 2024
Seed Round	$7.85M	6	RA Capital Management, SVG Ventures \| THRIVE +4	12 Jul 2022
Seed Round	Undisclosed	1	Breakout Labs	30 Apr 2019
Pre Seed Round	Undisclosed	1	SVG Ventures \| THRIVE	24 Apr 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

Undisclosed

U.S. Department of Agriculture

11 Mar 2024

Seed Round

$7.85M

RA Capital Management, SVG Ventures | THRIVE +4

12 Jul 2022

Seed Round

Undisclosed

Breakout Labs

30 Apr 2019

Pre Seed Round

Undisclosed

SVG Ventures | THRIVE

24 Apr 2018

FAQ About NAPIGEN, INC.

A biotech company that addresses novel genome engineering of various organisms such as plants, microbes and animals.

NAPIGEN, INC. was founded in 2016.

NAPIGEN, INC. is headquartered in Wilmington, United States.

NAPIGEN, INC. operates in Agriculture, Biotechnology and AgriTech. Its work centres on genome engineering, organelles, mitochondria and chloroplasts. Its customers include Agricultural Companies, Biotech Researchers and Academic Institutions.

NAPIGEN, INC. has a B2B, B2G and White Label business model. Its revenue comes from Licensing, Project Based and Service Fee.

NAPIGEN, INC. has approximately 21 employees.

NAPIGEN, INC. has completed 4 funding rounds, raising a total of $7.85M. The latest funding stage is Grant.

NAPIGEN, INC. offers: Genome Editing Technology Development, Mitochondrial and Chloroplast Research, Biotechnological Solutions for Agriculture.

Top alternatives and competitors to NAPIGEN, INC. include Liberation Labs, PLANTEDIT , Calysta. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

NAPIGEN, INC. and Liberation Labs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About NAPIGEN, INC.

Services & Products

Target Customers

Funding Rounds & Investors (4)

NAPIGEN, INC. Alternatives & Competitors

FAQ About NAPIGEN, INC.